Table 4 IC50 of compound C1 and cisplatin against the MDA-MB-231 cell line.

From: Anticancer activity of a monobenzyltin complex C1 against MDA-MB-231 cells through induction of Apoptosis and inhibition of breast cancer stem cells

Agent

IC50 ± SD (μg/mL)

 

24 hours

48 hours

Compound C1

3.5 ± 0.50

2.5 ± 0.50

Cisplatin

1.3 ± 0.61

0.9 ± 0.49

Back to article page